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112The role of atropine in carotid stenting of recurrent
stenosis after eversion endarterectomy
Serdar Demirel, MD,a Nicolas Attigah, MD,a Hans Bruijnen, MD,b Carola Wieker, MD,a and
Dittmar Böckler, MD,a Heidelberg and Munich, Germany
Objective: The value of prophylactic atropine use during carotid artery stenting (CAS) in primary carotid stenosis to
prevent procedural hemodynamic depression is well accepted. However, its impact in case of recurrent stenosis after
eversion carotid endarterectomy (E-CEA), which is known to be associated with decreased baroreﬂex function due to
discontinuation of the carotid sinus nerve, has not been investigated so far.
Methods: The inﬂuence of angioplasty in the carotid bulb on intraprocedural and periprocedural hemodynamic changes
(heart rate [HR], systolic blood pressure [SP], and diastolic blood pressure [DP]) of 38 CAS procedures (primary ste-
nosis group, n[ 16; post-E-CEA recurrent stenosis group, n[ 22) was analyzed retrospectively. A single dose of 0.5 mg
of atropine was administered in all cases immediately before angioplasty. Periprocedural vasoactive management was
documented. Within-group differences were analyzed by the nonparametric Friedman test with pairwise comparisons
following the method of Conover.
Results: Intraprocedural within-group comparison between the median of the 15-minute period before angioplasty and
each of three single measure points with 5-minute intervals after angioplasty showed a signiﬁcant decrease in almost all
measures for the primary stenosis group (HR: P[ .002, .0008, .08; SP: P[ .005, .01, .01; DP: P[ .04, .04, .01) and
the opposite for the post-E-CEA stenosis group (HR: P < .0001, <.0001, <.0001; SP: P [ .04, .03, .05; DP: P [ .23,
.06, .005). Whereas in comparison to baseline (day of admission), patients with primary stenosis showed a signiﬁcant
periprocedural decrease in HR (recovery room, P < .0001; 6-24 hours, P [ .0012; 25-48 hours, P [ .014) and SP
(recovery room, P < .0001; 6-24 hours, P < .0001; 25-48 hours, P < .0001), patients with restenosis after E-CEA revealed
no signiﬁcant changes with the exception of increased HR between 6 and 24 hours and decreased DP in the recovery
room.
Conclusions: The application of atropine during CAS for recurrent carotid stenosis after prior E-CEA might not be
necessary. (J Vasc Surg 2015;61:112-8.)Carotid artery stenting (CAS) emerged as an accept-
able alternative to carotid endarterectomy (CEA) in highly
selected patients with atherosclerotic carotid artery disease,
even though randomized controlled trials and meta-
analyses comparing both techniques are ambiguous.1-7
During CAS, the stretching of the sinus baroreceptors
may induce dysfunction of the baroreﬂex system, leading to
hemodynamic instability.8,9 The baroreceptors (or pressor-
eceptors) are stretch receptors located in the carotid sinuses
and in the aortic arch. Impulses that arise in the carotid si-
nus after deformation of the vessel travel up the sinus nerve
to the glossopharyngeal nerve and, through it, to the nu-
cleus tractus solitarius in the medulla. Stimulation of the
nucleus tractus solitarius inhibits the sympathetic activity,the Department of Vascular and Endovascular Surgery, Ruprecht-
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://dx.doi.org/10.1016/j.jvs.2014.06.117resulting in peripheral vasodilation and bradycardia, elicited
by stimulation of the vagal nuclei in the medulla.10
Although there is little impact of restenosis on the rate
of recurrent ischemic stroke,1,4,11,12 indication criteria for
carotid interventions are identical to criteria for de novo
stenoses.13 The impact of prophylactic atropine administra-
tion on CAS-induced bradycardia in patients with prior
CEA has been evaluated only once by Cayne et al.14 How-
ever, in this unique study, the speciﬁc type of CEA tech-
nique was not mentioned. Prior studies showed that
eversion carotid endarterectomy (E-CEA) is associated
with decreased baroreceptor sensitivity due to technique-
related dissection of the carotid bulb and thus denervation
of the carotid sinus nerve,15,16 which represents a crucial
station of the baroreceptor reﬂex pathway. The aim of
this study was to determine whether prophylactic atropine
use during CAS in patients with post-eversion endarterec-
tomy restenosis is necessary.METHODS
Between January 2006 and December 2013, a total of
62 patients with symptomatic or asymptomatic carotid ar-
tery stenosis were treated with CAS. Of these, 26 (42%)
had a primary stenosis and 36 (58%) a recurrent carotid ar-
tery stenosis after ipsilateral E-CEA. The internal carotid
artery (ICA) stenosis was associated with more than 70%
diameter reduction in all patients. ICA stenosis was
Table I. Demographics: comparison of patients with
primary lesions and patients with prior eversion carotid
endarterectomy (E-CEA)
Variable
Primary
(n ¼ 16), %
After E-CEA
(n ¼ 22), % P value
Age, years,
mean 6 SD
68.57 6 8.99 73.41 6 7.64 .08
Male 9 (56.3) 18 (81.8)
Female 7 (43.7) 4 (18.2) .18
ASA class
1 0 (0) 0 (0) >.99
2 4 (25) 5 (22.7)
3 12 (75) 17 (77.3)
4 0 (0) 0 (0)
CHF 3 (18.8) 9 (40.1) .15
Hypertension 14 (87.5) 20 (90.9) .74
Prior MI 2 (12.5) 6 (27.3) .27
CAD 4 (25) 12 (54.5) .07
Prior PTCA-stent 2 (12.5) 5 (22.7) .42
Prior CAB 1 (6.3) 4 (18.2) .28
PAD 5 (31.3) 10 (45.5) .38
COPD 1 (6.3) 1 (4.5) .82
Diabetes 3 (18.8) 4 (18.2) .96
Renal insufﬁciency 1 (6.3) 1 (4.5) .82
Hypercholesterolemia 9 (56.3) 14 (63.6) .65
Smoking 4 (25) 6 (27.3) .88
Symptomatic 1 (6.3) 2 (9.1) .75
Stenosis grade, %,
median (IQR)
85 (75-90) 80 (80-90) .78
Contralateral ICA
occlusion
11 (68.8) 5 (22.7) .005
On antihypertensive
medication
14 (87.5) 21 (95.5) .37
ASA, American Society of Anesthesiologists; CAB, coronary artery bypass;
CAD, coronary artery disease; CHF, congestive heart failure; COPD,
chronic obstructive pulmonary disease; ICA, internal carotid artery; IQR,
interquartile range; MI, myocardial infarction; PAD, peripheral arterial
disease; PTCA, percutaneous transluminal coronary angioplasty; SD, stan-
dard deviation.
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by computed tomography angiography of the supra-aortic
vessels in all cases. Computed tomography angiography
was routinely used to assess the aortic arch branching pattern
and the grade of calciﬁcation. After obtaining Institutional
Review Board approval and informed consent, data referring
to patient demographics, operative details, and short-term
follow-up were collected prospectively in a computerized
vascular registry. Hemodynamic assessment and periproce-
dural vasoactive management were extracted retrospectively
on the basis of the content of patient charts pertaining to
preoperative, intraoperative, and postoperative periods.
The 38 patients requiring an angioplasty before or after stent
placement were included in the study (primary stenosis, n¼
16; post-E-CEA stenosis, n ¼ 22). In the primary stenosis
group, indications for CAS were contralateral occlusion in
11 cases (69%), contralateral post-CEA laryngeal nerve palsy
in three cases (19%), and severe comorbidities in two cases
(12%). CAS was the primary option in recurrent carotid ste-
nosis due to the accumulation of scar tissue after ipsilateral
CEA and thus the higher risk of cranial nerve injury.13
Baseline blood pressure and heart rate (HR) values
recorded as three noninvasive measurements at both arms
were obtained on the day of admission. HR and blood pres-
sure were continuously monitored throughout the intrapro-
cedural period as well as during the period in the recovery
room by electrocardiography and a radial artery catheter.
Measures were documented every 5minutes during the pro-
cedure and hourly for at least 5 hours after the procedure
was ﬁnished. Postprocedural blood pressure and HR values
were recorded by noninvasive measurements of each arm
three times a day until discharge, which usually was the sec-
ond postoperative day. Blood pressure was always measured
on both arms, and the higher pressure was used.
Intraprocedural systolic blood pressure (SP) and dia-
stolic blood pressure (DP) values as well as HR values dur-
ing the 15-minute period before or after dilation were
averaged for each group and compared with every single
averaged value 5, 10, and 15 minutes and hourly after an-
gioplasty for 5 hours. In addition, preprocedural measure-
ments on the day of admission were compared with
postprocedural values of the ﬁrst and second days after CAS.
A single atropine bolus of 0.5 mg was administered
prophylactically in all cases within a 5-minute time frame
before balloon dilation, which was necessary either before
or after CAS. Lesion dilation before stent deployment
was usually preferred in subocclusive or severely calciﬁed
vessels. In cases of suboptimal stent expansion, postdilation
was necessary to achieve a good vessel opaciﬁcation. Hypo-
tension (SP <90 mm Hg) was treated with an intravenous
bolus of ephedrine (Akrinor). All preoperative vasoactive
medications and perioperative alterations in vasoactive
management were documented. Vasoactive medications,
including beta blockade, were not discontinued during
the study period. The deﬁnition of postoperative severe hy-
pertension was settled by $ 180 mm Hg of SP.
Statistical analysis. The Shapiro-WilkW test was used
to analyze the distribution of numerical data, which wereanalyzed with unpaired t-test or with Mann-WhitneyU test
as appropriate.
The Fisher-Freeman-Halton exact test was used for
analysis of proportions of baseline data, procedural details,
and postprocedural need of vasoactive therapy. The effect
of carotid bulb dilation on blood pressure and HR in
each group was analyzed by the nonparametric Friedman
test with pairwise comparisons following the method of
Conover. StatsDirect statistical software version 2.7.3
(StatsDirect Ltd, Altrincham, Cheshire, United Kingdom)
was used for analyses. Two-sided P values were always
computed, and a difference was considered statistically sig-
niﬁcant at P # .05.
RESULTS
By the time of CAS, ICA stenosis was asymptomatic in
35 patients (92.1%) and symptomatic in three patients
(7.9%). Mean ages and comorbidities did not differ be-
tween both groups, and the proportion of patients taking
antihypertensive medication was similar (Table I). All pa-
tients receiving antihypertensive medication in both groups
Table II. Comparison of predilation and postdilation
measurements of hemodynamic parameters in the
post-eversion carotid endarterectomy (E-CEA) group
including the ﬁrst 5 hours in the recovery room
Predilation
(5-15 minutes) Postdilation
P value
Signiﬁcance
of difference
HR, beats/minute,
median (IQR) Median (IQR)
59 (54-70) 5 minutes 71 (65-85) <.0001
10 minutes 79 (64-85) <.0001
15 minutes 74 (62-84) <.0001
1 hour 63 (60-80) .0004
2 hours 62 (56-72) .02
3 hours 61 (55-68) .40
4 hours 61 (56-70) .25
5 hours 60 (60-69) .09
SP, mm Hg,
median (IQR)
140 (130-150) 5 minutes 140 (140-160) .04
10 minutes 145 (130-160) .03
15 minutes 150 (130-160) .05
1 hour 135 (120-160) .50
2 hours 130 (120-150) .31
3 hours 130 (120-145) .08
4 hours 130 (120-145) .20
5 hours 140 (120-145) .12
DP, mm Hg,
median (IQR)
70 (65-80) 5 minutes 80 (65-85) .23
10 minutes 77.5 (70-80) .06
15 minutes 80 (70-85) .005
1 hour 80 (70-90) .06
2 hours 70 (60-80) .89
3 hours 67.5 (60-80) .20
4 hours 70 (65-80) .72
5 hours 70 (60-72.5) .30
DP, Diastolic blood pressure; HR, heart rate; IQR, interquartile range; SP,
systolic blood pressure.
Table III. Comparison of predilation and postdilation
measurements of hemodynamic parameters in the
primary stenosis group including the ﬁrst 5 hours in
the recovery room
Predilation
(5-15 minutes) Postdilation
P value
Signiﬁcance
of difference
HR, beats/minute,
median (IQR) Median (IQR)
69 (64-79) 5 minutes 61 (50-65) .002
10 minutes 63 (56.5-71) .0008
15 minutes 67 (58-80) .08
1 hour 70 (60-70) .62
2 hours 62 (60-67.5) .009
3 hours 64.5 (60-68) .0008
4 hours 60 (60-64.5) .02
5 hours 63 (60-70) .005
SP, mm Hg,
median (IQR)
150 (140-160) 5 minutes 140 (130-160) .005
10 minutes 137.5 (130-150) .01
15 minutes 140 (130-150) .01
1 hour 130 (120-170) .0001
2 hours 120 (115-170) <.0001
3 hours 120 (120-180) <.0001
4 hours 122.5 (110-170) <.0001
5 hours 130 (110-150) <.0001
DP, mm Hg,
median (IQR)
70 (65-70) 5 minutes 62.5 (60-70) .04
10 minutes 65 (52.5-70) .04
15 minutes 62.5 (52.5-70) .01
1 hour 60 (60-80) .08
2 hours 60 (50-70) .007
3 hours 60 (55-70) .02
4 hours 60 (55-70) .01
5 hours 60 (60-65) .06
DP, Diastolic blood pressure; HR, heart rate; IQR, interquartile range; SP,
systolic blood pressure.
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group showed higher rates of contralateral carotid occlu-
sion. Mean degree of stenosis was 85% (interquartile range,
75%-90%) in the primary stenosis group and 80% (inter-
quartile range, 80%-90%) in the post-E-CEA stenosis
group. The overall mean interval between E-CEA and
CAS was 54.6 months (range, 5.1-176.8 months).
Intraprocedural hemodynamic measurements. In
the post-E-CEA stenosis group, there was a signiﬁcant
increase in HR during the ﬁrst 2 hours after dilation in
comparison to the predilation time frame of 15 minutes.
The postdilation SP values showed a signiﬁcant increase
during 15 minutes. With the exception of the value after
15 minutes, no signiﬁcant change in DP was observed
(Table II). On the contrary, in the primary stenosis group,
almost all measurements showed a signiﬁcant decrease dur-
ing the whole postdilation time frame of 5 hours (Table III).
Fig 1 shows intraprocedural HR and blood pressure trac-
ings of one representative subject from each group.Periprocedural hemodynamic measurements. The
HR and blood pressure measured at each periprocedural
time period are presented in Tables IV and V and addi-
tionally in Fig 2, illustrating the within-group development
of the postoperative SP. Compared with baseline (day of
admission), no signiﬁcant change was observed in the post-
E-CEA group with the exception of increased HR between
6 and 24 hours and decreased DP in the recovery room;
whereas in the primary stenosis group, the complete
postoperative period was associated with lower blood
pressure and HR values with the exception of DP between
25 and 48 hours after CAS.
Postprocedural vasoactive management. Two of 16
patients (12.5%) in the primary stenosis group showed
hypotension (SP < 90 mm Hg) during the 5 hours in
the recovery room and received ephedrine (Akrinor). In
contrast, none of the post-E-CEA patients required
ephedrine (P ¼ .09). On the surgical ward, no vasocon-
strictors were necessary in each group. No patient in both
Fig 1. Intraprocedural heart rate (HR) and blood pressure (BP) tracings over time. Data are shown as individual values
of one subject from each group (A) after eversion endarterectomy and (B) with primary stenosis. Compared with the
predilation period of 15 minutes, the intraprocedural values within 15 minutes after atropine administration and
balloon dilation were increased in the post-eversion endarterectomy subject with the exception of diastolic blood
pressure (DP). In contrast, the primary stenosis subject showed a decrease of all measures during the whole postdilation
time of 5 hours.
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hypertension, and atropine was not necessary for brady-
cardia. There were no cardiac or neurologic postoperative
complications.
DISCUSSION
This study demonstrated that in cases of recurrent ste-
nosis after eversion endarterectomy of the carotid artery,
atropine use is not necessary during CAS-related balloon
angioplasty. Patients in the primary stenosis group with
an intact carotid sinus nerve showed a signiﬁcant decrease
of intraprocedural and postprocedural HR and blood pres-
sure in the initial postoperative 48 hours. Conversely, the
post-E-CEA group showed an increased intraprocedural
and a generally unchanged postprocedural cardiovascular
activity in comparison to baseline. This is the ﬁrst trial
addressing the aspect of hemodynamic changes by CAS
in patients with prior ipsilateral E-CEA.
Exclusion of patients without pre-stent or post-stent
angioplasty was necessary owing to the experience ofBussiere et al.17 Bussiere et al investigated the hemody-
namic instability during CAS in relation to self-expanding
stent deployment (n ¼ 77) vs balloon dilation (n ¼ 20).
The authors concluded that intraprocedural bradycardia
and hypotension during and after CAS was observed
more frequently when balloon angioplasty was required.
Obviously, there is a more intense response of the pressor-
eceptor nerve terminals in the walls of the carotid sinus to
the stretch and deformation induced by angioplasty rather
than by the self-expanding pressure of the stent alone. This
phenomenon has been seen in several other studies in the
past.9,14,18-22
Bradycardia and hypotension in the immediate post-
procedural period are a common occurrence after carotid
artery stenosis treatment with CAS and have been attrib-
uted to the stimulation of the carotid sinus baroreceptors
located in the carotid bifurcation.9,18-25 E-CEA routinely
was performed with complete mobilization of the carotid
bifurcation, including transection of the carotid sinus
nerve.
Table IV. Comparison of preprocedural (baseline)
and postprocedural hemodynamic measures in the
post-eversion carotid endarterectomy (E-CEA) group
Baseline (day of admission) Postoperative
P value
Signiﬁcance
of difference
HR, beats/minute, median (IQR)
69 (61-76) 60 (56-70)a .0558
70 (64-78)b .0471
69 (64-78)c .1431
SP, mm Hg, median (IQR)
130 (122.5-140) 132.5 (120-150)a .8378
137.5 (127.5-142.5)b .3768
140 (130-145)c .3415
DP, mm Hg, median (IQR)
75 (70-80) 70 (60-80)a .0028
80 (70-80)b .8758
72.5 (70-80)c .6396
DP, Diastolic blood pressure; HR, heart rate; IQR, interquartile range; SP,
systolic blood pressure.
aIn the recovery room.
bAt 6 to 24 hours.
cAt 25 to 48 hours.
Table V. Comparison of preprocedural (baseline) and
postprocedural hemodynamic measures in the primary
stenosis group
Baseline (day of admission) Postoperative
P value
Signiﬁcance
of difference
HR, beats/minute, median (IQR)
78 (70-80) 62 (60-67.5)a <.0001
67 (62-74)b .0012
72 (64-80)c .0149
SP, mm Hg, median (IQR)
140 (137.5-140) 115 (105-120)a <.0001
120 (110-125)b <.0001
120 (120-130)c <.0001
DP, mm Hg, median (IQR)
74.5 (70-80) 60 (55-70)a <.0001
60 (60-79)b .0347
70 (70-75)c .7178
DP, Diastolic blood pressure; HR, heart rate; IQR, interquartile range; SP,
systolic blood pressure.
aIn the recovery room.
bAt 6 to 24 hours.
cAt 25 to 48 hours.
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fect of surgical denervation of the carotid sinus nerve dur-
ing E-CEA, baroreﬂex sensitivity dropped signiﬁcantly after
surgery, with changes persisting on the third postoperative
day.15 Another subsequent study, conducted because of
the lack of a control group of the former study, conﬁrmed
the decreasing effect of E-CEA on baroreﬂex sensitivity
compared with conventional CEA with patch angio-
plasty.16 This pathophysiologic inﬂuence may represent
the main cause for increased postoperative blood pressure
after E-CEA as suggested in two retrospective studies by
Mehta et al26 and our working group.27 Another study
investigated not only the short-term but also the midterm
effect of both techniques on blood pressure and ongoing
antihypertensive medication.28 In this study, E-CEA was
associated with higher ambulatory blood pressure measure-
ments during the postoperative course of 3 days, leading to
a more frequent use of vasodilators. Midterm results
showed no difference of average blood pressure values
but, interestingly, an increased maximal blood pressure
and HR reached in the E-CEA group and a decreased
HR in the conventional CEA group. Compared with base-
line, the number of antihypertensive medications at
midterm (9.5 months [median]) was signiﬁcantly higher
in the E-CEA group (median [interquartile range], 3 [2-
3] vs 2 [2-3]; P ¼ .002). This clinical difference can be
explained by permanent ipsilateral loss of baroreceptor re-
ﬂex due to the discontinuity of the carotid sinus nerve,
which is a crucial station of neural interaction with the me-
dulla oblongata. Furthermore, once the blood pressure and
HR increase because of reduced afferent impulses of the
ipsilateral carotid sinus, a higher threshold to produce
baroreceptor ﬁring of the intact contralateral carotid sinus
develops. This kind of resetting refers to the phenomenonwhereby the baroreﬂex operating range and pressure
threshold shift in the direction of the arterial pressure
change.29
Consistent with previous results, the current study
showed no autonomic cardiovascular reaction in the post-
E-CEA stenosis group during angioplasty of the carotid
bulb, assuming that the ipsilateral baroreceptor apparatus
of the carotid bulb has no function because of prior surgical
denervation. Instead, HR increased initially when atropine
was administered, in contrast to a signiﬁcant drop in the
primary stenosis group. Even though it is speculative,
without atropine blockade, a signiﬁcant difference between
treatment groups with regard to the clinical end point of
procedural hypotension/bradycardia would most likely
occur. Therefore, in patients with recurrent ICA stenosis
after E-CEA, atropine use might not be necessary during
balloon angioplasty of the carotid bulb. In contrast to
our results, Marrocco-Trischitta et al30 recently showed
in patients with a history of bilateral eversion endarterec-
tomy, undergoing cardiovascular reﬂex tests and spectral
analysis of HR and SP variability, that E-CEA does not
confer permanent carotid sinus denervation. However,
the noninvasive methods used by the authors (lying to
standing, orthostatic hypotension, deep breathing, Valsalva
maneuver) indicated in testing the integrity of parasympa-
thetic cholinergic cardiovagal function also triggers alter-
ations in cardiopulmonary and aortic arch baroreceptors,
thus making HR and blood pressure ﬂuctuations poorly
speciﬁc. To conclude that E-CEA is not associated with
permanent loss of carotid baroreceptor function, the au-
thors could have applied the neck chamber method, which
is also noninvasive. The neck chamber device consists of a
rigid chamber sealed around the subject’s neck, in which
the air pressure is increased or reduced in a graded fashion,
Fig 2. Box plots displaying periprocedural change in systolic
blood pressure (SP). A, Post-eversion endarterectomy group. B,
Primary stenosis group. Compared with the baseline (day of
admission) predilation SP, the follow-up SPs were unchanged in
the post-eversion endarterectomy group and signiﬁcantly reduced
in the primary stenosis group. The horizontal lines in the boxes
indicate the median and the boxes represent the lower quartile
(25%) and upper quartile (75%) values.
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in carotid transmural pressure. The key advantage of the
neck chamber method is that it allows assessment of HR
and blood pressure modulation speciﬁcally by carotid baro-
receptors.31 In the current study, unilateral carotid barore-
ﬂex function could be assessed in an invasive way, allowing
a full pressure transmission to the carotid baroreceptors
located in the carotid bulb. This maneuver is even more
effective than the neck chamber method because the pres-
sure changes produced within a neck chamber are not fully
transmitted through the neck tissues to the carotid
baroreceptors.32,33
Atropine is a widely used medication during CAS.
Because of its anticholinergic action, it prevents
baroreceptor-stimulated bradycardia and hypotension,
which may complicate CAS for severe carotid stenosis.
However, besides tachycardia and a general rise of blood
pressure, use of atropine can lead to common side effects
like dry mouth, photophobia, blurred vision, retention of
urine, and constipation and in rare cases to centralanticholinergic syndrome, a potential serious complication
after administration even of lower doses of atropine than
are normally used during CAS.34,35 Even though there
was no documented case with any of the potential atropine
side effects, we think that in post-E-CEA restenosis,
routine prophylactic atropine use before or after stent an-
gioplasty during CAS should be avoided.
This study was primarily designed to evaluate intra-
group modiﬁcations of intraprocedural and periprocedural
hemodynamic changes and suffers from all of the limita-
tions inherent in any retrospective study. A systematic
screening with electrocardiographic or laboratory values
to see if any patient suffered from cardiac ischemia as well
as screening for atropine side effects was not done. Longer
term comparative studies are needed to determine if in
post-eversion recurrent carotid stenosis, atropine use dur-
ing CAS is associated with increased cardiovascular and
neurologic morbidity. The major limitation of our study
is the small sample size, which provides only limited statis-
tical power for comparison between groups. However, the
different reactions of both groups to transmural pressure
transmission in the carotid bulb demonstrate that E-CEA
is associated with permanent loss of carotid baroreﬂex
function.
CONCLUSIONS
In patients undergoing CAS for recurrent stenosis after
E-CEA, administration of atropine can most likely be dis-
claimed. This phenomenon is attributed to permanent
loss of baroreﬂex function of the ipsilateral carotid bulb.
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